B

Braveheart Bio

Develops cardiac myosin inhibitors for HCM

Associate Director/Director - Medical Affairs, Publications

Biology & BiotechConfirmed live in the last 24 hours
Full-timeSan Francisco, CA, USA

About the Job

Requirements

  • An advanced scientific degree (MD, PhD, PharmD, or equivalent) is required.
  • Associate Director candidates must have 5+ years of publications or scientific communications experience in biotech/pharma or a medical communications agency; Director candidates must have 8+ years, including leading publication strategy for a late-stage or launch asset.
  • Proven experience with strategic publication planning and execution across all phases of drug development, including high-impact journal manuscripts and major congress presentations.
  • In-depth knowledge of Good Publication Practice (GPP), International Committee of Medical Journal Editors (ICMJE), Consolidated Standards of Reporting Trials (CONSORT), and related guidance for scientific data communication.
  • Solid understanding of clinical trial design, statistical methods, and clinical data reporting.
  • Demonstrated success working in a matrixed, cross-functional environment and influencing without authority.
  • Strong scientific writing, editing, and data interpretation skills, with the ability to translate complex data into clear, compelling communications.
  • Experience managing external agencies, authors, and budgets to deliver projects on time and on budget.
  • Strong organizational and project management skills, with the ability to manage multiple concurrent deliverables and deadlines.
  • Ability to work independently and collaboratively in a fast-moving, resource-lean environment and remain comfortable with change and ambiguity.
  • Ability to travel domestically and internationally approximately 15–20%, including to major congresses.
  • Participation in the federal E-Verify program requires employment authorization verification for all new hires.

Responsibilities

  • Develop, own, and maintain the integrated strategic publication plan, including congress disclosures.
  • Identify and prioritize publication opportunities across the evidence lifecycle, including clinical (Phase 1–3, long-term extension, subgroup, and pooled analyses), clinical pharmacology (pharmacokinetics/pharmacodynamics, population pharmacokinetics, drug-drug interactions, and ethno-bridging), nonclinical/mechanistic, health economics and outcomes research, disease-state and review articles, and real-world evidence.
  • Define journal and congress targeting strategies, including late-breaking submissions and simultaneous publications timed with major data presentations.
  • Maintain a backlog of future publication concepts and track emerging data to ensure key datasets are published.
  • Lead abstract, poster, oral presentation, and manuscript development for major cardiovascular and hypertrophic cardiomyopathy congresses and relevant specialty meetings.
  • Manage submission calendars and deadlines to ensure timely delivery of high-quality, data-driven materials.
  • Plan publications around key data readouts and topline disclosures, coordinating timing with Corporate Communications and Investor Relations.
  • Monitor competitive readouts and the external scientific landscape to inform timing, positioning, and messaging of BHB-1893 data.
  • Serve as the publications lead on cross-functional teams, partnering with Clinical Development, Biostatistics and Programming, Clinical Operations, Clinical Pharmacology, Nonclinical, Regulatory, health economics and outcomes research, Legal and Compliance, and Commercial within appropriate boundaries.
  • Work with Biostatistics and Clinical teams to align publication timelines with database locks, data cuts, and tables, figures, and listings availability.
  • Collaborate with licensing partner Hengrui Pharma to coordinate joint publications, data sharing, authorship, and alignment.
  • Engage investigators, steering committee members, and external authors to lead or co-author publications and facilitate author meetings and review cycles.
  • Ensure consistent scientific messaging across publications, medical communications, field medical materials, and training.
  • Lead development and maintenance of reactive scientific content, including slide decks, frequently asked questions, standard response documents, and other materials addressing unsolicited scientific inquiries and emerging medical needs.
  • Partner cross-functionally with Medical Affairs, Clinical Development, Biostatistics, Regulatory, Legal, and Compliance to ensure scientific accuracy, consistency, and appropriate review of reactive content.
  • Work with Field Medical and other internal stakeholders to identify content needs, incorporate insights, and prioritize content development.
  • Ensure reactive scientific content is evidence-based, appropriately balanced, and aligned with the scientific narrative and available clinical data.
  • Coordinate content review, approval, version control, and periodic updates to keep materials accurate and current.
  • Build and implement publications infrastructure, including standard operating procedures, a publication steering committee, review and approval workflows, and a publication management system.
  • Ensure publications comply with GPP, ICMJE, CONSORT, and company policies, including authorship criteria, conflict-of-interest disclosures, transparency, and audit-ready documentation.
  • Select and/or manage publication and medical writing agencies, overseeing scope, timelines, quality, and budget.
  • Develop and track publication metrics and report progress to cross-functional stakeholders.
  • Contribute to broader Medical Affairs activities as needed, including advisory boards, scientific training, and medical communications.

Desired Qualifications

  • Background or publication experience in cardiovascular medicine, ideally hypertrophic cardiomyopathy, heart failure, or cardiac myosin inhibitors.
  • Certified Medical Publication Professional (CMPP) certification.
  • Experience with late-breaking clinical trial presentations and simultaneous publications.
  • Experience with global publications involving ex-US or licensing partners, particularly China-generated data.
  • Experience building a publications function or processes at a small-to-mid-size biotech.
  • Familiarity with health economics and outcomes research/real-world evidence publications and clinical pharmacology data.
  • Hands-on experience with publication management platforms.

About the Company

Braveheart Bio

Develops cardiac myosin inhibitors for HCM

Braveheart Bio develops therapies for hypertrophic cardiomyopathy by in-licensing promising drug candidates and advancing them through late-stage clinical trials. Its lead drug, BHB-1893, is a selective small-molecule cardiac myosin inhibitor licensed from Hengrui Pharma for ex-China rights, designed to reduce contractility in heart cells and improve heart performance. The company differentiates itself by pursuing a best-in-class profile with potential improvements in efficacy, safety, and dosing, supported by a high-profile leadership team and investors. Its goal is to bring an approved, globally accessible therapy for HCM that delivers meaningful clinical benefit.

Company size
51-200
Company stage
IPO
Headquarters
San Francisco, CA
Founded
2025

Recently Posted Jobs

Explore more opportunities at Braveheart Bio

See more jobs